Royalty Pharma Reports Q4 and Full Year 2024 Results
Go back to Royalty Pharma Reports Q4 and Full Year 2024 Results| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 58.61 -0.14 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.75 | 52 Week High | $3.48 | |||
| Open | $58.95 | 52 Week Low | $0.80 | |||
| Day High | $59.54 | P/E | N/A | |||
| Day Low | $58.35 | EPS | $-1.54 | |||
| Volume | 2,596,068 | |||||

